WeChat

简体中文
 

Achievements

  • [Nature Communications] Escalating Transmissibility of Severe Fever with Thrombocytopenia Syndrome in a High-Endemic Region of China

    2026-05-13
  • [Nature Communications] A biomimetic nanodisc system selectively activates type I interferons by nonclassical STING pathway for cancer immunotherapy

    2026-04-09
  • [Science Advances] Cold Atmospheric Plasma Engineered Nanovaccine with Spatiotemporal Sequential Immunization Reprograms Antitumor Immunity

    2026-04-08
  • [ACS Nano] Combination mRNA Vaccine Adjuvanted with CpG Oligodeoxynucleotides Enhances Protection against Respiratory Virus Infection

    2026-03-31
  • [Cell Reports Medicine] A bispecific nanobody‒drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer

    2026-03-19
  • [Nature Communications] A selective enrichment and specific probe terminal mediated strategy for highly sensitive detection of microRNAs

    2026-03-17
  • [Nature Communications] XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures

    2026-03-14
  • [Nature Communications] Engineering NIR-II carbon dots through aniline extension with graphene and nitrogen enrichment for hepatobiliary theranostics

    2026-03-05
  • [Nature Communications] Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma

    2026-03-03
  • [Science Bulletin] Immunogenicity and Safety of an Escherichia coli-produced 9-valent HPV Vaccine in Adolescents Aged 9 to 17 Compared with Young Women

    2026-02-28
    • FirstPrevious123456NextLast